Halozyme Therapeutics Inc. Common Stock vs Smurfit WestRock plc Ordinary Shares — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $112.19 (market cap $12.58B), while Smurfit WestRock plc Ordinary Shares trades at $41.27 (market cap $21.74B). The key difference: Smurfit WestRock plc Ordinary Shares is the larger of the two by market cap, and Smurfit WestRock plc Ordinary Shares pays a 4.36% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 0 Days and Smurfit WestRock plc Ordinary Shares for 0 Days on average.
| HALO | SW | |
|---|---|---|
Market Cap | $12.58B | $21.74B |
Volume | 2,179,278 | 5,178,763 |
Sector | Health | Consumer Cyclical |
52-Week High | $115.22 | $51.84 |
52-Week Low | $61.63 | $32.79 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $14.49B | $35.23B |
Dividend Yield | — | 4.36% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →Smurfit WestRock plc is an Ireland-headquartered packaging company that manufactures corrugated containers and consumer packaging from containerboard and paperboard, operating mills, converting plants, and recycling facilities across more than 40 countries.
Read more on SW →